Cardiovascular

Printing and PDF export are disabled for this protected preview. Continue reading inside the DiraChart reader.

Trace DC35-3

DiraChart Clinical Reference
Protected section 3 of 26
← Document menu
Home Care · DiraChart

1. Purpose and clinical relevance

DiraChart Clinical Reference

Section NavigationPart 3 of 26PreviousNext

2. What the clinician must assess

A complete cardiovascular assessment addresses each of the following each visit, scaled to the patient's diagnosis and stability:

  • Heart rate and rhythm — rate, regularity, and apical pulse for a full minute when the rhythm is irregular, with apical–radial deficit noted if present.
  • Heart sounds — S1 and S2; presence of S3 or S4, murmurs, or a rub.
  • Blood pressure against the patient-specific ordered parameters, with orthostatic measurements when symptoms or fall risk are present.
  • Jugular venous distension / estimated venous pressure at 30–45°.
  • Peripheral perfusion — pulse amplitude and symmetry (radial, dorsalis pedis, posterior tibial), capillary refill, and extremity temperature and color.
  • Peripheral edema — location, grade, symmetry, and whether pitting.
  • Volume status — daily-weight trend versus baseline and target/dry weight, and fluid-balance signals.
  • Symptom screen — chest pain or pressure, palpitations, dyspnea, orthopnea, PND, dizziness, syncope, claudication, and change in activity tolerance.
  • Medication regimen — cardioactive drugs (diuretics, ACE-inhibitors/ARBs/ARNIs, beta-blockers, anticoagulants, antiarrhythmics, nitrates): adherence, effect, and adverse effects.
  • Functional and activity tolerance and any change from baseline.
  • Relevant comorbid interactions — renal, endocrine, and pulmonary status that affect cardiovascular stability.
Section NavigationPart 3 of 26PreviousNext